Aparently, after doing some research, not getting approved for re-embursement is not that big of a deal in Canada:
The agency recommends not listing for alot of drugs including Lyrica [Pfizer - great drug here in the US and EU], Nexavar [Bayer - renal cell carcinoma], etc. Canada Public reimbursement is less concerned about patients and more about costs...they go with cheap when alternatives [even inferior ones] are available which is why private health care [which does cover Thelin] is catching on like fire.
News 
Market Data 
Discover 
